Mercer Capital Advisers’s Bristol-Myers Squibb BMY Stock Holding History

Mercer Capital Advisers’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$190K	Sell	3,208 -100	-3%	-$6.59K	0.1%	99
2021 Q2	$221K	Hold	3,308	–	–	0.11%	96
2021 Q1	$209K	Sell	3,308 -1,782	-35%	-$111K	0.11%	95
2020 Q4	$316K	Hold	5,090	–	–	0.18%	71
2020 Q3	$307K	Buy	5,090 +100	+2%	+$6.02K	0.19%	68
2020 Q2	$299K	Hold	4,990	–	–	0.19%	69
2020 Q1	$278K	Hold	4,990	–	–	0.21%	62
2019 Q4	$320K	Hold	4,990	–	–	0.19%	73
2019 Q3	$253K	Buy	4,990 +1,000	+25%	+$47K	0.16%	78
2019 Q2	$181K	Hold	3,990	–	–	0.12%	99
2019 Q1	$190K	Hold	3,990	–	–	0.13%	95
2018 Q4	$207K	Hold	3,990	–	–	0.15%	83
2018 Q3	$248K	Hold	3,990	–	–	0.17%	85
2018 Q2	$221K	Hold	3,990	–	–	0.16%	87
2018 Q1	$252K	Hold	3,990	–	–	0.19%	82
2017 Q4	$244K	Hold	3,990	–	–	0.18%	81
2017 Q3	$254K	Hold	3,990	–	–	0.19%	81
2017 Q2	$222K	Hold	3,990	–	–	0.17%	85
2017 Q1	$217K	Hold	3,990	–	–	0.17%	85
2016 Q4	$233K	Hold	3,990	–	–	0.19%	82
2016 Q3	$215K	Hold	3,990	–	–	0.17%	84
2016 Q2	$293K	Hold	3,990	–	–	0.24%	69
2016 Q1	$255K	Hold	3,990	–	–	0.22%	73
2015 Q4	$274K	Buy	3,990 +200	+5%	+$13.2K	0.24%	73
2015 Q3	$224K	Hold	3,790	–	–	0.21%	84
2015 Q2	$252K	Hold	3,790	–	–	0.23%	80
2015 Q1	$244K	Hold	3,790	–	–	0.22%	79
2014 Q4	$224K	Buy	+3,790	New	+$214K	0.2%	83

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Mercer Capital Advisers's BMY Position: Q3 2021 in Review

Mercer Capital Advisers reduced its Bristol-Myers Squibb (BMY) stake by 3% in Q3 2021, selling an estimated $6.59K and leaving 3,208 shares worth $190K. The position accounts for 0.1% of the portfolio, ranked #99.

Mercer Capital Advisers first reported a position in BMY in Q4 2014 and has held it in 28 quarters since. The position peaked at $320K in Q4 2019. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Mercer Capital Advisers held 3,208 shares of Bristol-Myers Squibb worth $190K as of Q3 2021.
Mercer Capital Advisers sold 100 Bristol-Myers Squibb shares in Q3 2021, an estimated $6.59K.
Bristol-Myers Squibb made up 0.1% of Mercer Capital Advisers's portfolio in Q3 2021, its #99 holding.
Mercer Capital Advisers first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 28 quarters since.
Mercer Capital Advisers's Bristol-Myers Squibb position peaked at $320K in Q4 2019.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Mercer Capital Advisers's 13F filing for Q3 2021, filed 27 Oct 2021.